| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.32 | 0.08 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.33 | 0.09 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.09 |